Srs Capital Advisors, Inc. Abbott Laboratories Transaction History

Srs Capital Advisors, Inc.

$977 Million
Q2 2024

A detailed history of Srs Capital Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 4,634 shares of ABT stock, worth $526,237. This represents 0.05% of its overall portfolio holdings.

Number of Shares

4,634

Previous 2,558 81.16%

Holding current value

$526,237

Previous $290,000 65.86%

% of portfolio

0.05%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$100.73 - $112.44 $209,115 - $233,425	2,076 Added 81.16%	4,634 $481,000
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $152,232 - $168,134	-1,390 Reduced 35.21%	2,558 $290,000
Q4 2023 Feb 06, 2024	SELL	$90.19 - $110.4 $36,076 - $44,160	-400 Reduced 9.2%	3,948 $434,000
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $121,418 - $145,682	1,271 Added 41.31%	4,348 $421,000
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $12,899 - $14,373	128 Added 4.34%	3,077 $335,000
Q1 2023 May 16, 2023	SELL	$96.86 - $114.01 $10,751 - $12,655	-111 Reduced 3.63%	2,949 $298,000
Q4 2022 Feb 24, 2023	SELL	$95.06 - $111.52 $6,273 - $7,360	-66 Reduced 2.11%	3,060 $336,000
Q3 2022 Nov 03, 2022	BUY	$96.76 - $112.03 $48,960 - $56,687	506 Added 19.31%	3,126 $302,000
Q2 2022 Aug 22, 2022	BUY	$102.07 - $123.37 $45,931 - $55,516	450 Added 20.74%	2,620 $285,000
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $37,056 - $45,188	325 Added 17.62%	2,170 $257,000
Q4 2021 Feb 08, 2022	SELL	$115.53 - $141.46 $22,528 - $27,584	-195 Reduced 9.56%	1,845 $260,000
Q3 2021 Nov 05, 2021	BUY	$116.66 - $129.06 $1,516 - $1,677	13 Added 0.64%	2,040 $241,000
Q2 2021 Aug 02, 2021	BUY	$105.79 - $124.53 $14,599 - $17,185	138 Added 7.31%	2,027 $235,000
Q4 2020 Feb 03, 2021	SELL	$105.0 - $114.42 $36,645 - $39,932	-349 Reduced 15.59%	1,889 $207,000
Q2 2020 Aug 06, 2020	BUY	$76.57 - $98.0 $6,508 - $8,330	85 Added 3.95%	2,238 $205,000
Q1 2020 May 13, 2020	BUY	$62.82 - $91.86 $22,049 - $32,242	351 Added 19.48%	2,153 $170,000
Q3 2019 Nov 01, 2019	BUY	$81.84 - $88.74 $81 - $88	1 Added 0.06%	1,802 $151,000
Q2 2019 Aug 08, 2019	SELL	$72.88 - $85.0 $4,810 - $5,610	-66 Reduced 3.54%	1,801 $151,000
Q4 2018 Feb 06, 2019	SELL	$65.56 - $74.27 $6,424 - $7,278	-98 Reduced 4.99%	1,867 $135,000
Q3 2018 Nov 06, 2018	SELL	$60.81 - $73.36 $35,999 - $43,429	-592 Reduced 23.15%	1,965 $144,000
Q2 2018 Aug 21, 2018	BUY	$57.57 - $63.54 $147,206 - $162,471	2,557 New	2,557 $155,000
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $24,196 - $27,356	-430 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$53.68 - $57.47 $536 - $574	10 Added 2.38%	430 $24,000
Q3 2017 Nov 15, 2017	BUY	$48.06 - $53.64 $20,185 - $22,528	420	420 $22,000

Others Institutions Holding ABT

# of Institutions

3,136

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.

Account

Srs Capital Advisors, Inc. Abbott Laboratories Transaction History